細胞増殖市場：製品、細胞タイプ、用途、エンドユーザー別-2024～2030年の世界予測

細胞増殖市場規模は2023年に193億6,000万米ドルと推定され、2024年には209億米ドルに達し、CAGR 8.23%で2030年には337億米ドルに達すると予測されています。

細胞増殖とは、少数の初期集団から多数の細胞を培養することを指します。この手順は、医薬品開発、再生医療、臨床研究など、バイオテクノロジーの様々なセグメントの基礎となっています。このプロセスでは、細胞を制御された条件下で培養し、特定の特性や機能性を維持しながらその数を増やすことが含まれます。細胞増殖は、研究者や臨床医が治療への応用、調査研究、あるいはさらなる生物学的製造工程に十分な量の細胞を確保できるようにする上で極めて重要です。細胞培養技術、バイオリアクター、オートメーションにおける技術革新は、細胞増殖プロセスのスケーラビリティと効率を向上させました。糖尿病、がん、心血管疾患の世界の罹患率の増加は、再生療法とバイオ医薬品の需要を促進し、細胞増殖市場の成長を煽っています。しかし、細胞増殖機器や消耗品に関連する費用が市場成長の課題となっています。個別化医療と患者に特化した治療への注目の高まりが、細胞増殖市場の成長機会をもたらしています。

製品：研究とバイオ医薬品製造における不可欠な反復使用により、細胞増殖で消耗品の使用が拡大

消耗品とは、試薬、培地、血清、使い捨てバイオリアクターシステムなど、細胞増殖全体を通じて定期的に使用され、交換される製品を指します。これらの材料は試験管内での細胞の維持と増殖に不可欠です。ディスポーザブルとは、汚染を防ぎ、細胞増殖のための滅菌環境を確保するために設計された、フラスコ、プレート、チューブなどの使い捨て品のことです。これらは、細胞増殖過程における細胞培養の完全性を維持するために極めて重要です。培地とは、細胞の成長と増殖に必要な栄養豊富な溶液を指します。培地は、標的細胞集団の特定のニーズを満たすように注意深く調合されなければならず、最適な増殖結果を保証します。試薬は、分化や増殖といった細胞増殖に必要な生物学的反応やプロセスを促進します。血清は、必須成長因子、ホルモン、栄養素を提供し、 細胞増殖をサポートします。無血清培地がよりコントロールされた条件下で使用される傾向にありますが、血清は多くの細胞種にとって依然として重要です。細胞増殖に含まれる器具には、バイオリアクター、細胞培養容器、遠心分離機など、プロセスに不可欠なハードウェアや装置が含まれます。これらの機器は、細胞増殖に必要な制御された環境を促進し、最適な増殖のための正確な条件を確実に維持します。自動化された細胞増殖システムは、より高い精度と制御を提供し、労力の軽減とコンタミネーションのリスクの低減によるスケーラブルな細胞増殖を可能にします。このシステムは、細胞培養のセグメントにおいて必要不可欠な技術的進歩です。マイクロキャリア・バイオリアクターは、浮遊培養で接着細胞を増殖させるための表面を提供するマイクロキャリアを利用し、制御された環境での大規模な細胞増殖を容易にします。灌流または中空糸バイオリアクターは、廃棄物を除去しながら培養液に新鮮培地を連続的に供給することにより、最適な増殖条件を維持し、高密度の細胞集団を増殖させます。セルカウンターと血球計数装置は、細胞密度と生存率をモニターするために不可欠です。これらのツールは、望ましいペースで増殖が進み、プロセス全体を通して細胞が健全であることを保証します。遠心分離機は、細胞を培地やその他の溶液から分離するために使用されます。遠心分離機は、細胞増殖ワークフローにおける細胞採取と下流処理に不可欠です。フローサイトメーターは、生存率、純度、表現型の特徴を含む細胞集団の詳細な分析を提供し、拡大細胞の品質と一貫性を保証します。

用途：再生医療におけるエルの拡大、世界の再生治療のための幹細胞研究

がんや細胞を用いた研究において、腫瘍の成長動態やがん細胞に対する様々な薬剤の効果の調査を容易にすることで、細胞増殖は極めて重要な役割を果たしています。このアプリケーションは、潜在的ながん治療法を特定し、細胞レベルでがんの生物学を理解するために不可欠であり、より効果的な治療法を開発するための道筋を記載しています。再生医療や幹細胞研究のセグメントでは、組織の再生や修復などの治療応用に必要な細胞を十分な量生成するために、細胞増殖が不可欠です。このプロセスは、損傷した組織や臓器を置換または修復する幹細胞の力を利用することにより、変性疾患を含む様々な疾患の治療法の開発をサポートし、個別化医療の進歩を促進します。

地域別洞察

米国は、堅調なバイオテクノロジーと製薬部門、研究開発（R&D）への多額の投資、業界をリードする参入企業の強力なプレゼンスにより、南北アメリカの細胞増殖市場を独占しています。同地域では、自動細胞増殖システムやバイオリアクターなど、研究・治療用途に対応した先端技術の採用率が高いです。カナダとブラジルにおける細胞増殖市場の有望な成長は、医療研究に対する政府資金の増加、細胞治療が必要な慢性疾患の有病率の上昇、幹細胞研究と治療開発に対する規制支援に起因しています。アジア太平洋は、経済成長、医療支出の増加、バイオテクノロジー研究への注目の高まりにより、細胞増殖市場のダイナミックなエリアとして台頭してきています。中国、日本、韓国、オーストラリアのような国々は、幹細胞研究と再生医療に多額の投資を行い、最先端を走っています。中国の細胞増殖における著しい成長は、バイオテクノロジー研究を強化する政府の努力によって推進されています。日本の強力な製薬部門と再生医療に対する良好な規制環境は、この地域のこのセグメントでの市場開拓を大きく前進させています。欧州・中東・アフリカ地域は、欧州の技術進歩、研究開発活動、細胞ベースの治療法の採用が顕著であり、多様な市場情勢を示しています。ドイツ、英国、フランスが重要な貢献国であり、有利な政府政策、広範な研究インフラ、学界と産業界の協力関係によって支えられています。アフリカ地域の細胞増殖市場は、バイオテクノロジーの研究活動の増加、医療インフラへの投資の増加、高度な治療アプローチを必要とする慢性疾患の有病率の増加によって成長しています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは細胞増殖市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を記載しています。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、細胞増殖市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、このセグメントの競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています。

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を記載しています。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発とイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を記載しています。

本レポートは、以下のような主要な質問に対応しています。

1.細胞増殖市場の市場規模と予測は？

2.細胞増殖市場の予測期間中に投資を検討すべき製品、用途は何か？

3.細胞増殖市場の技術動向と規制枠組みは？

4.細胞増殖市場における主要ベンダーの市場シェアは？

5.細胞増殖市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 細胞培養技術の技術的進歩
    • 世界中でがん、糖尿病、心血管疾患の発生率が上昇
    • 幹細胞研究と再生医療の研究開発への継続的な投資
  • 抑制要因
    • 細胞増殖機器や消耗品のコストが高い
  • 機会
    • 細胞増殖のマイクロ流体デバイスの統合
    • バイオプリンティング技術の進歩が組織工学と再生医療に革命をもたらす
  • 課題
    • 細胞ベースの治療法の承認に関する複雑な規制状況
• 市場セグメンテーション分析
  • 製品：研究やバイオ医薬品製造において不可欠な繰り返し使用のため、細胞増殖における消耗品の使用を拡大
  • 用途：再生医療と再生治療のための幹細胞調査における世界の拡大
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 細胞増殖市場：製品別

• イントロダクション
• 消耗品
• 機器

第7章 細胞増殖市場：細胞タイプ別

• イントロダクション
• 動物細胞
• ヒト細胞

第8章 細胞増殖市場：用途別

• イントロダクション
• がんと細胞ベースの研究
• 再生医療と幹細胞研究
• ワクチン製造

第9章 細胞増殖市場：エンドユーザー別

• イントロダクション
• バイオテクノロジーとバイオ医薬品企業
• 細胞バンク
• 研究機関

第10章 南北アメリカの細胞増殖市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の細胞増殖市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの細胞増殖市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年年
• 競合シナリオ分析
• 戦略分析と提言

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. CELL EXPANSION MARKET RESEARCH PROCESS
• FIGURE 2. CELL EXPANSION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CELL EXPANSION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CELL EXPANSION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL CELL EXPANSION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. CELL EXPANSION MARKET DYNAMICS
• FIGURE 7. GLOBAL CELL EXPANSION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL CELL EXPANSION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL CELL EXPANSION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL CELL EXPANSION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS CELL EXPANSION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS CELL EXPANSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES CELL EXPANSION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES CELL EXPANSION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL EXPANSION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. CELL EXPANSION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. CELL EXPANSION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CELL EXPANSION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CELL EXPANSION MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL CELL EXPANSION MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL CELL EXPANSION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL CELL EXPANSION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL CELL EXPANSION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL CELL EXPANSION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL CELL EXPANSION MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL CELL EXPANSION MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL CELL EXPANSION MARKET SIZE, BY DISPOSABLES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL CELL EXPANSION MARKET SIZE, BY MEDIA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL CELL EXPANSION MARKET SIZE, BY MEDIA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL CELL EXPANSION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL CELL EXPANSION MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL CELL EXPANSION MARKET SIZE, BY SERA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL CELL EXPANSION MARKET SIZE, BY SERA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL CELL EXPANSION MARKET SIZE, BY AUTOMATED CELL EXPANSION SYSTEM, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL CELL EXPANSION MARKET SIZE, BY AUTOMATED CELL EXPANSION SYSTEM, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL CELL EXPANSION MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL CELL EXPANSION MARKET SIZE, BY BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL CELL EXPANSION MARKET SIZE, BY MICROCARRIER BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL CELL EXPANSION MARKET SIZE, BY MICROCARRIER BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL CELL EXPANSION MARKET SIZE, BY PERFUSION OR HOLLOW FIBER BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL CELL EXPANSION MARKET SIZE, BY PERFUSION OR HOLLOW FIBER BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL COUNTERS & HEMOCYTOMETERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL COUNTERS & HEMOCYTOMETERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL CELL EXPANSION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL CELL EXPANSION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL CELL EXPANSION MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL CELL EXPANSION MARKET SIZE, BY FLOW CYTOMETERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL CELL EXPANSION MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL CELL EXPANSION MARKET SIZE, BY ANIMAL CELLS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL CELL EXPANSION MARKET SIZE, BY DIFFERENTIATED CELLS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL CELL EXPANSION MARKET SIZE, BY DIFFERENTIATED CELLS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL CELL EXPANSION MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL CELL EXPANSION MARKET SIZE, BY STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL CELL EXPANSION MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL CELL EXPANSION MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL CELL EXPANSION MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL CELL EXPANSION MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL CELL EXPANSION MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL CELL EXPANSION MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELLS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 65. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 66. GLOBAL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 67. GLOBAL CELL EXPANSION MARKET SIZE, BY CANCER & CELL-BASED RESEARCH, BY REGION, 2018-2023 (USD MILLION)
• TABLE 68. GLOBAL CELL EXPANSION MARKET SIZE, BY CANCER & CELL-BASED RESEARCH, BY REGION, 2024-2030 (USD MILLION)
• TABLE 69. GLOBAL CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE & STEM CELL RESEARCH, BY REGION, 2018-2023 (USD MILLION)
• TABLE 70. GLOBAL CELL EXPANSION MARKET SIZE, BY REGENERATIVE MEDICINE & STEM CELL RESEARCH, BY REGION, 2024-2030 (USD MILLION)
• TABLE 71. GLOBAL CELL EXPANSION MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 72. GLOBAL CELL EXPANSION MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 73. GLOBAL CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 74. GLOBAL CELL EXPANSION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 75. GLOBAL CELL EXPANSION MARKET SIZE, BY BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 76. GLOBAL CELL EXPANSION MARKET SIZE, BY BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 77. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL BANKS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 78. GLOBAL CELL EXPANSION MARKET SIZE, BY CELL BANKS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 79. GLOBAL CELL EXPANSION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 80. GLOBAL CELL EXPANSION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 81. AMERICAS CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 82. AMERICAS CELL EXPANSION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 83. AMERICAS CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 84. AMERICAS CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 85. AMERICAS CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 86. AMERICAS CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 87. AMERICAS CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 88. AMERICAS CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 89. AMERICAS CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 90. AMERICAS CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 91. AMERICAS CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 92. AMERICAS CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 93. AMERICAS CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 94. AMERICAS CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 95. AMERICAS CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2023 (USD MILLION)
• TABLE 96. AMERICAS CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2024-2030 (USD MILLION)
• TABLE 97. AMERICAS CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 98. AMERICAS CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 99. AMERICAS CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 100. AMERICAS CELL EXPANSION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 101. AMERICAS CELL EXPANSION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 102. AMERICAS CELL EXPANSION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 103. ARGENTINA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 104. ARGENTINA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 105. ARGENTINA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 106. ARGENTINA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 107. ARGENTINA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 108. ARGENTINA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 109. ARGENTINA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 110. ARGENTINA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 111. ARGENTINA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 112. ARGENTINA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 113. ARGENTINA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 114. ARGENTINA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 115. ARGENTINA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 116. ARGENTINA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 117. ARGENTINA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2023 (USD MILLION)
• TABLE 118. ARGENTINA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2024-2030 (USD MILLION)
• TABLE 119. ARGENTINA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 120. ARGENTINA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 121. ARGENTINA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 122. ARGENTINA CELL EXPANSION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 123. BRAZIL CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 124. BRAZIL CELL EXPANSION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 125. BRAZIL CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 126. BRAZIL CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 127. BRAZIL CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 128. BRAZIL CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 129. BRAZIL CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 130. BRAZIL CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 131. BRAZIL CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 132. BRAZIL CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 133. BRAZIL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 134. BRAZIL CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 135. BRAZIL CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 136. BRAZIL CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 137. BRAZIL CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2023 (USD MILLION)
• TABLE 138. BRAZIL CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2024-2030 (USD MILLION)
• TABLE 139. BRAZIL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 140. BRAZIL CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 141. BRAZIL CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 142. BRAZIL CELL EXPANSION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 143. CANADA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 144. CANADA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 145. CANADA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 146. CANADA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 147. CANADA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 148. CANADA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 149. CANADA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 150. CANADA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 151. CANADA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 152. CANADA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 153. CANADA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 154. CANADA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 155. CANADA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 156. CANADA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 157. CANADA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2023 (USD MILLION)
• TABLE 158. CANADA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2024-2030 (USD MILLION)
• TABLE 159. CANADA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 160. CANADA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 161. CANADA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 162. CANADA CELL EXPANSION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 163. MEXICO CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 164. MEXICO CELL EXPANSION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 165. MEXICO CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 166. MEXICO CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 167. MEXICO CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 168. MEXICO CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 169. MEXICO CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 170. MEXICO CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 171. MEXICO CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 172. MEXICO CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 173. MEXICO CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 174. MEXICO CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 175. MEXICO CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 176. MEXICO CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 177. MEXICO CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2023 (USD MILLION)
• TABLE 178. MEXICO CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2024-2030 (USD MILLION)
• TABLE 179. MEXICO CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 180. MEXICO CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 181. MEXICO CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 182. MEXICO CELL EXPANSION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 183. UNITED STATES CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 184. UNITED STATES CELL EXPANSION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 185. UNITED STATES CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 186. UNITED STATES CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 187. UNITED STATES CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 188. UNITED STATES CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 189. UNITED STATES CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 190. UNITED STATES CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 191. UNITED STATES CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 192. UNITED STATES CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 193. UNITED STATES CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 194. UNITED STATES CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 195. UNITED STATES CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 196. UNITED STATES CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 197. UNITED STATES CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2023 (USD MILLION)
• TABLE 198. UNITED STATES CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2024-2030 (USD MILLION)
• TABLE 199. UNITED STATES CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 200. UNITED STATES CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 201. UNITED STATES CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 202. UNITED STATES CELL EXPANSION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 203. UNITED STATES CELL EXPANSION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 204. UNITED STATES CELL EXPANSION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 205. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 206. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 207. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 208. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 209. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 210. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 211. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 212. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 213. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 214. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 215. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 216. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 217. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 218. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 219. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2023 (USD MILLION)
• TABLE 220. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2024-2030 (USD MILLION)
• TABLE 221. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 222. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 223. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 224. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 225. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 226. ASIA-PACIFIC CELL EXPANSION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 227. AUSTRALIA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 228. AUSTRALIA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 229. AUSTRALIA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 230. AUSTRALIA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 231. AUSTRALIA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 232. AUSTRALIA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 233. AUSTRALIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 234. AUSTRALIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 235. AUSTRALIA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 236. AUSTRALIA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 237. AUSTRALIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 238. AUSTRALIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 239. AUSTRALIA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 240. AUSTRALIA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 241. AUSTRALIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2023 (USD MILLION)
• TABLE 242. AUSTRALIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2024-2030 (USD MILLION)
• TABLE 243. AUSTRALIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 244. AUSTRALIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 245. AUSTRALIA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 246. AUSTRALIA CELL EXPANSION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 247. CHINA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 248. CHINA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 249. CHINA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 250. CHINA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 251. CHINA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 252. CHINA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 253. CHINA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 254. CHINA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 255. CHINA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 256. CHINA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 257. CHINA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 258. CHINA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 259. CHINA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 260. CHINA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 261. CHINA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2023 (USD MILLION)
• TABLE 262. CHINA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2024-2030 (USD MILLION)
• TABLE 263. CHINA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 264. CHINA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 265. CHINA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 266. CHINA CELL EXPANSION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 267. INDIA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 268. INDIA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 269. INDIA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 270. INDIA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 271. INDIA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 272. INDIA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 273. INDIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 274. INDIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 275. INDIA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 276. INDIA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 277. INDIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 278. INDIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 279. INDIA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 280. INDIA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 281. INDIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2023 (USD MILLION)
• TABLE 282. INDIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2024-2030 (USD MILLION)
• TABLE 283. INDIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 284. INDIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 285. INDIA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 286. INDIA CELL EXPANSION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 287. INDONESIA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 288. INDONESIA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 289. INDONESIA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 290. INDONESIA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 291. INDONESIA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 292. INDONESIA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 293. INDONESIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 294. INDONESIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 295. INDONESIA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 296. INDONESIA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 297. INDONESIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 298. INDONESIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 299. INDONESIA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 300. INDONESIA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 301. INDONESIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2023 (USD MILLION)
• TABLE 302. INDONESIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2024-2030 (USD MILLION)
• TABLE 303. INDONESIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 304. INDONESIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 305. INDONESIA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 306. INDONESIA CELL EXPANSION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 307. JAPAN CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 308. JAPAN CELL EXPANSION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 309. JAPAN CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 310. JAPAN CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 311. JAPAN CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 312. JAPAN CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 313. JAPAN CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 314. JAPAN CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 315. JAPAN CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 316. JAPAN CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 317. JAPAN CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 318. JAPAN CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 319. JAPAN CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 320. JAPAN CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 321. JAPAN CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2023 (USD MILLION)
• TABLE 322. JAPAN CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2024-2030 (USD MILLION)
• TABLE 323. JAPAN CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 324. JAPAN CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 325. JAPAN CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 326. JAPAN CELL EXPANSION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 327. MALAYSIA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 328. MALAYSIA CELL EXPANSION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 329. MALAYSIA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 330. MALAYSIA CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 331. MALAYSIA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 332. MALAYSIA CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 333. MALAYSIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 334. MALAYSIA CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 335. MALAYSIA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 336. MALAYSIA CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 337. MALAYSIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 338. MALAYSIA CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 339. MALAYSIA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 340. MALAYSIA CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)
• TABLE 341. MALAYSIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2018-2023 (USD MILLION)
• TABLE 342. MALAYSIA CELL EXPANSION MARKET SIZE, BY STEM CELLS, 2024-2030 (USD MILLION)
• TABLE 343. MALAYSIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 344. MALAYSIA CELL EXPANSION MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 345. MALAYSIA CELL EXPANSION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 346. MALAYSIA CELL EXPANSION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 347. PHILIPPINES CELL EXPANSION MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 348. PHILIPPINES CELL EXPANSION MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 349. PHILIPPINES CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2018-2023 (USD MILLION)
• TABLE 350. PHILIPPINES CELL EXPANSION MARKET SIZE, BY CONSUMABLES, 2024-2030 (USD MILLION)
• TABLE 351. PHILIPPINES CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 352. PHILIPPINES CELL EXPANSION MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 353. PHILIPPINES CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2018-2023 (USD MILLION)
• TABLE 354. PHILIPPINES CELL EXPANSION MARKET SIZE, BY BIOREACTORS, 2024-2030 (USD MILLION)
• TABLE 355. PHILIPPINES CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2018-2023 (USD MILLION)
• TABLE 356. PHILIPPINES CELL EXPANSION MARKET SIZE, BY CELL EXPANSION SUPPORTING EQUIPMENT, 2024-2030 (USD MILLION)
• TABLE 357. PHILIPPINES CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2018-2023 (USD MILLION)
• TABLE 358. PHILIPPINES CELL EXPANSION MARKET SIZE, BY CELL TYPE, 2024-2030 (USD MILLION)
• TABLE 359. PHILIPPINES CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2018-2023 (USD MILLION)
• TABLE 360. PHILIPPINES CELL EXPANSION MARKET SIZE, BY HUMAN CELLS, 2024-2030 (USD MILLION)

TABLE 3

[197 Pages Report] The Cell Expansion Market size was estimated at USD 19.36 billion in 2023 and expected to reach USD 20.90 billion in 2024, at a CAGR 8.23% to reach USD 33.70 billion by 2030.

Cell expansion refers to cultivating a large number of cells from a small initial population. This procedure is fundamental to various fields within biotechnology, including drug development, regenerative medicine, and clinical research. The process involves cultivating cells under controlled conditions to increase their number while maintaining their specific characteristics or functionality. Cell expansion is crucial in enabling researchers and clinicians to have sufficient quantities of cells for therapeutic applications, research studies, or further biological manufacturing processes. The innovations in cell culture technologies, bioreactors, and automation have improved the scalability and efficiency of cell expansion processes. The growing incidence of diabetes, cancer, and cardiovascular diseases globally drives demand for regenerative therapies and biopharmaceuticals, fueling the growth of the cell expansion market. However, the expenses associated with cell expansion instruments and consumables challenges the market growth. The increasing focus on personalized medicine and patient-specific treatments offers opportunities for the growth of the cell expansion market.

Product: Expanding use of consumables in cell expansion due to their essential, repetitive use in research and biopharmaceutical production

Consumables refer to products such as reagents, media, sera, and disposable bioreactor systems that are regularly used and replaced throughout the cell expansion. These materials are crucial for the maintenance and proliferation of cells in vitro. Disposables are single-use items such as flasks, plates, and tubes designed to prevent contamination and ensure a sterile environment for cell growth. They are crucial for maintaining the integrity of cell cultures during the expansion process. Media refers to the nutrient-rich solutions required for cell growth and proliferation. Media must be carefully formulated to meet the specific needs of the target cell population, ensuring optimal expansion outcomes. Reagents facilitate biological reactions and processes necessary for cell growth, such as differentiation and proliferation. Sera provides essential growth factors, hormones, and nutrients that support cell expansion. Despite the trend towards serum-free media for more controlled conditions, sera remains crucial for many cell types. Instruments in cell expansion encompass the hardware and devices essential for the process, including bioreactors, cell culture vessels, and centrifuges. These instruments facilitate the controlled environment necessary for cell growth, ensuring precise conditions are maintained for optimal expansion. Automated cell expansion systems offer higher precision and control, enabling scalable cell expansion with reduced labor and a lower risk of contamination. They represent an essential technological advancement in the field of cell culture. Microcarrier bioreactors utilize microcarriers that provide a surface for adherent cells to grow in a suspended culture, facilitating large-scale cell expansion in a controlled environment. Perfusion or hollow fiber bioreactors operate by continuously feeding fresh media into the culture while removing waste, maintaining optimal growth conditions and expanding high-density cell populations. Cell counters & hemocytometers are essential for monitoring cell density and viability; these tools ensure that expansion proceeds at the desired pace and that cells remain healthy throughout the process. Centrifuges are used to separate cells from media and other solutions; centrifuges are vital for cell harvesting and downstream processing in the expansion workflow. Flow cytometers provide detailed analysis of cell populations, including viability, purity, and phenotypic characteristics, ensuring the quality and consistency of expanded cells.

Application: ell expansion in regenerative medicine & stem cell research for regenerative treatments globally

In cancer and cell-based research, cell expansion plays a pivotal role by facilitating the study of tumor growth kinetics and the effects of various drugs on cancer cells. This application is critical for identifying potential cancer treatments and understanding cancer biology at a cellular level, thus offering a pathway toward developing more effective therapies. Within regenerative medicine and stem cell research, cell expansion is indispensable for generating sufficient quantities of cells required for therapeutic applications, such as tissue regeneration and repair. This process supports the development of treatments for various conditions, including degenerative diseases, by harnessing the power of stem cells to replace or repair damaged tissues and organs, furthering the advancement of personalized medicine.

Regional Insights

The United States dominates the cell expansion market in the Americas due to its robust biotechnology and pharmaceutical sectors, significant investments in research and development (R&D), and strong presence of leading industry players. The region witnesses a high adoption rate of advanced technologies, including automated cell expansion systems and bioreactors, catering to research and therapeutic applications. The promising growth of the cell expansion market in Canada and Brazil can be attributed to increased government funding for healthcare research, the rising prevalence of chronic diseases requiring cell therapy treatments, and regulatory support for stem cell research and therapy development. The Asia-Pacific region is emerging as a dynamic area in the cell expansion market, driven by economic growth, growing healthcare expenditure, and an increasing focus on biotechnology research. Countries like China, Japan, South Korea, and Australia are at the forefront, investing significantly in stem cell research and regenerative medicine. China's significant growth in cell expansion is propelled by governmental efforts to enhance biotechnology research. Japan's robust pharmaceutical sector and favorable regulatory environment for regenerative medicine majorly advance the region's market development in this field. The EMEA region showcases a diverse landscape for the cell expansion market, with Europe showcasing significant technological advancement, R&D activities, and adoption of cell-based therapies. Germany, the United Kingdom, and France are vital contributors, supported by favorable government policies, extensive research infrastructure, and collaborations between academia and industry. The cell expansion market in the African region is growing, driven by increasing research activities in biotechnology, rising investments in healthcare infrastructure, and the growing prevalence of chronic diseases requiring advanced therapeutic approaches.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cell Expansion Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cell Expansion Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cell Expansion Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Bio-Techne Corporation, Celltainer Biotech B.V., Corning Incorporated, Cytiva, Danaher Corporation, Eppendorf SE, G&G Technologies, Inc., GE Healthcare, iXCells Biotechnologies, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Neuromics, NexImmune, Novartis AG, PromoCell GmbH, REPROCELL Inc., Sartorius AG, Scinus Cell Expansion, Stemcell Technologies, Inc., Takara Bio Inc., Terumo BCT, TERUMO BCT, INC., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Expansion Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Consumables
    • Disposables
    • Media
    • Reagents
    • Sera

• Instruments
  • Automated Cell Expansion System
  • Bioreactors
    • Microcarrier Bioreactors
    • Perfusion or Hollow Fiber Bioreactors

• Cell Expansion Supporting Equipment
  • Cell Counters & Hemocytometers
  • Centrifuges
  • Flow Cytometers
• Cell Type
  • Animal Cells
  • Human Cells
    • Differentiated Cells
    • Stem Cells
      • Adult Stem Cells
      • Embryonic Stem Cells
      • Induced Pluripotent Stem Cells
• Application
  • Cancer & Cell-Based Research
  • Regenerative Medicine & Stem Cell Research
  • Vaccine Production

• End-User
  • Biotechnology & Biopharmaceutical Companies
  • Cell Banks
  • Research Institutes

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cell Expansion Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cell Expansion Market?

3. What are the technology trends and regulatory frameworks in the Cell Expansion Market?

4. What is the market share of the leading vendors in the Cell Expansion Market?

5. Which modes and strategic moves are suitable for entering the Cell Expansion Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Technological advancements in cell culture technologies
    • 5.1.1.2. Rising incidence of cancer, diabetes, and cardiovascular diseases worldwide
    • 5.1.1.3. Ongoing investments in R&D in stem cell research and regenerative medicine
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of cell expansion instruments and consumables
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of microfluidic devices for cell expansion
    • 5.1.3.2. Advancements in bioprinting technologies to revolutionize tissue engineering and regenerative medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Complex regulatory landscape for approval of cell-based therapies
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Expanding use of consumables in cell expansion due to their essential, repetitive use in research and biopharmaceutical production
  • 5.2.2. Application: ell expansion in regenerative medicine & stem cell research for regenerative treatments globally
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Cell Expansion Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Instruments

7. Cell Expansion Market, by Cell Type

• 7.1. Introduction
• 7.2. Animal Cells
• 7.3. Human Cells

8. Cell Expansion Market, by Application

• 8.1. Introduction
• 8.2. Cancer & Cell-Based Research
• 8.3. Regenerative Medicine & Stem Cell Research
• 8.4. Vaccine Production

9. Cell Expansion Market, by End-User

• 9.1. Introduction
• 9.2. Biotechnology & Biopharmaceutical Companies
• 9.3. Cell Banks
• 9.4. Research Institutes

10. Americas Cell Expansion Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cell Expansion Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cell Expansion Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. A Strategic Collaboration Between Thermo Fisher Scientific and Multiply Labs, Revolutionizing Cell Therapy Manufacturing through Automation
  • 13.3.2. luri Launches PluriCDMO for Advanced Cell Therapy Manufacturing Services
  • 13.3.3. Akadeum Life Sciences Advances Cell Therapy Research with Innovative Cell Isolation and Expansion Kits
• 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio